CClinicalTrials.gg
Status unknownNCT03733665Updated Feb 20, 2020

HES and NICOR Data Linkage for Cardiac Failure Population Analysis

An observational study in Heart Failure, Registries and Patient Readmission, sponsored by King's College London. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-20.

Sponsored by King's College London · Observational

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
80,000
Ages
18 Years and older
Sex
All
01

Study summary

This study is a population-based, patient-level analysis of heart failure in England over a 5-year period using a dataset created by linking HES and NICOR databases. Our analyses will look into the re-occurrence of hospitalisation after the initial diagnosis of heart failure, the influence of population factors on risk of re-hospitalisation, and the resultant cost implications in an NHS environment.

Read the detailed description

Data from the National Heart Failure Audit (NICOR) and Hospital Episodes Statistics (NHS Digital) will be linked, by NHS Digital, using fields that are recorded in both databases (for example, NHS number). We will receive de-anonymised data that has been pseudo-anonymised, allowing for patient-level analyses but without identifying individual patients.

02

Conditions studied

  • Heart Failure
  • Registries
  • Patient Readmission

Browse trials for

Keywords

  • Hospital Episode Statistics
  • HES
  • National Institute for Cardiovascular Outcomes Research
  • NICOR
  • National Heart Failure Audit
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 80,000 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

King's College London is the lead sponsor of 506 studies on the registry; 125 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Acute decompensated heart failure (ADHF) is a sudden worsening of the signs and symptoms of heart failure, which typically includes difficulty breathing (dyspnoea) and leg oedema. ADHF is a common and potentially serious cause of acute respiratory distress. Treatment of ADHF consists of reducing the excess fluid retention with diuretics along with improving heart function with pharmacological treatment. Although pharmacological treatments exist for heart failure patients with reduced ejection fraction (ACE inhibitors, beta-blockers), a substantial fraction of patients exhibit preserved ejection fraction where treatment consists solely of management of comorbidities and symptoms.

Inclusion criteria

  • patients >17 years old
  • individual patient data appears on both HES and NICOR databases
  • 4-character primary diagnosis codes I50.0-I50.9

Exclusion criteria

Exclusion Criteria:

  • patient requests withdrawal from analyses
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
80,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Heart failure patients

    All patients in NICOR's National Heart Failure Audit will be matched to those in NHS Digital's HES database who have a 4-character primary diagnosis of I50.0-I50.9.

    Other: Patients admitted to hospital

Interventions

  • OtherPatients admitted to hospital

    Data is captured in HES for all patient interactions with the NHS (each episode) in England. All patients admitted for heart failure have data captured in the National Heart Failure Audit.

06

What researchers measure

Primary outcomes

  1. Readmission

    Any repeat hospitalisation for heart failure

    Time frame: 2012-2017

07

Study locations

1 site
  • King's College London
    London, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03733665
Lead sponsor
King's College London
Responsible party
Sponsor
First posted
Nov 7, 2018
Start date
Nov 6, 2018
Primary completion
Oct 31, 2020 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
Feb 20, 2020

Study contacts

Anastasia Chalkidou
principal investigator · King's College London

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion